BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30572733)

  • 1. Sexual dysfunction in perimenopausal women based on a national epidemiological survey in China.
    Tong J; Zhang C; Zhu L; Zhang L; Jinghe L
    Climacteric; 2019 Apr; 22(2):190-194. PubMed ID: 30572733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Female Sexual Dysfunction Among Premenopausal Women: A Systematic Review and Meta-Analysis of Observational Studies.
    McCool ME; Zuelke A; Theurich MA; Knuettel H; Ricci C; Apfelbacher C
    Sex Med Rev; 2016 Jul; 4(3):197-212. PubMed ID: 27871953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of low sexual desire in Chinese women: a national population-based epidemiological survey in mainland China.
    Tong J; Zhang C; Zhang L; Xu T; Lang J; Zhu L
    Sex Health; 2020 Feb; 17(1):61-68. PubMed ID: 31945308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence and risk factors of female sexual dysfunction in young korean women: an internet-based survey.
    Song SH; Jeon H; Kim SW; Paick JS; Son H
    J Sex Med; 2008 Jul; 5(7):1694-701. PubMed ID: 18422495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexuality of Chinese women around menopause.
    Lo SS; Kok WM
    Maturitas; 2013 Feb; 74(2):190-5. PubMed ID: 23265305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related prevalence rates of sexual difficulties, sexual dysfunctions, and sexual distress in heterosexual women: results from an online survey in flanders.
    Hendrickx L; Gijs L; Enzlin P
    J Sex Med; 2015 Feb; 12(2):424-35. PubMed ID: 25345486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of female sexual dysfunction in urban chinese women based on cutoff scores of the Chinese version of the female sexual function index: a preliminary study.
    Ma J; Pan L; Lei Y; Zhang A; Kan Y
    J Sex Med; 2014 Apr; 11(4):909-919. PubMed ID: 24754329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Population-Based Epidemiologic Study of Female Sexual Dysfunction Risk in Mainland China: Prevalence and Predictors.
    Zhang C; Tong J; Zhu L; Zhang L; Xu T; Lang J; Xie Y
    J Sex Med; 2017 Nov; 14(11):1348-1356. PubMed ID: 29110805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women.
    Rosen RC; Maserejian NN; Connor MK; Krychman ML; Brown CS; Goldstein I
    Menopause; 2012 Apr; 19(4):396-405. PubMed ID: 22076307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of sexual dysfunction and potential risk factors that may impair sexual function in Malaysian women.
    Sidi H; Puteh SE; Abdullah N; Midin M
    J Sex Med; 2007 Mar; 4(2):311-21. PubMed ID: 17040486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, risk factors, and predictors of female sexual dysfunction in a primary care setting: a survey finding.
    Ishak IH; Low WY; Othman S
    J Sex Med; 2010 Sep; 7(9):3080-7. PubMed ID: 20584130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low sexual function and its associated risk factors in pre- and postmenopausal women without clinically significant depression.
    Verit FF; Verit A; Billurcu N
    Maturitas; 2009 Sep; 64(1):38-42. PubMed ID: 19632073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Female sexual dysfunction among married women in the Gaza Strip: an internet-based survey.
    Maasoumi R; Elsous A; Hussein H; Taghizadeh Z; Baloushah S
    Ann Saudi Med; 2019; 39(5):319-327. PubMed ID: 31580717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors for female sexual dysfunction among Egyptian women.
    Ibrahim ZM; Ahmed MR; Sayed Ahmed WA
    Arch Gynecol Obstet; 2013 Jun; 287(6):1173-80. PubMed ID: 23274790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
    Gregersen N; Jensen PT; Giraldi AE
    Dan Med Bull; 2006 Aug; 53(3):349-53. PubMed ID: 17092454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index, urinary incontinence, and female sexual dysfunction: how they affect female postmenopausal health.
    Pace G; Silvestri V; Gualá L; Vicentini C
    Menopause; 2009; 16(6):1188-92. PubMed ID: 19458558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and predictors of sexual function in midlife partnered Chinese women assessed by two simple indicators: Sexual frequency and sexual desire.
    Zhou Y; Li C; Jin F; Shao H; Teng Y; Tao M
    J Obstet Gynaecol Res; 2019 Jan; 45(1):210-216. PubMed ID: 30259615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal evaluation of sexual function in a cohort of pre- and postmenopausal women.
    Burri A; Hilpert P; Spector T
    J Sex Med; 2015 Jun; 12(6):1427-35. PubMed ID: 25940696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conceptualizing women's sexual function: linear vs. circular models of sexual response.
    Giles KR; McCabe MP
    J Sex Med; 2009 Oct; 6(10):2761-71. PubMed ID: 19686428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Gilbert L; Martel C; Balser J
    J Sex Med; 2014 Jul; 11(7):1766-85. PubMed ID: 24774442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.